Custom Peptides
Cayman Chemical RGDtargetd ProapoptoTCpep 10mg
A peptide; contains an integrin-binding cyclic region (CDCRGDCFC) and a region similar to a pro-apoptotic heptadimer sequence (klaklakklaklak), both of which are found in similar peptides
Cayman Chemical PrIstImerIn 10mg
A naturally occuring terpenoid that potently inhibits MAGL (IC50 = 93 nM); at 1 µM, significantly inhibits endogenous MAGL in isolated rat neurons
Cayman Chemical BetahIstInd3hydrochLRIde 10mg
An internal standard for the quantification of betahistine by GC- or LC-MS
Cayman Chemical ACTH7-38humntrIfluor 10mg
A peptide fragment of ACTH and an antagonist of MC2R; inhibits ACTH-induced corticosterone production in isolated rat adrenal cells at 0.455 or 4.55 µM; inhibits ACE1 (IC50 = 750 nM for the dog enzyme); inhibits basal cAMP secretion by isolated rat inner adrenocortical cells at 1 µM; induces hypotension in normotensive dogs (ED50 = 0.109 nmol/kg)
Cayman Chemical 17phenl trInor ProstglndI 10mg
A metabolically stable analog of PGF2α and potent FP receptor agonist (Ki = 1.1 nM at the rat FP receptor)
Cayman Chemical -BaclofenhydrochlorIde 10mg
A GABAB receptor agonist; increases latency to paw or tail withdrawal in the hot-plate test in mice at 1 and 3 mg/kg; reduces the number of lever responses for alcohol in Sardinian alcohol-preferring rats at 3 mg/kg
Cayman Chemical AcetoxyvalerenIc AcId 10mg
A sesquiterpenic acid; cytotoxic to GLC-4 and COLO 320 cells (IC50s = 111 and 124 µM, respectively)
Cayman Chemical PregntrIol 10mg
A metabolite of 17α-hydroxyprogesterone; urinary levels are elevated in patients with 21-hydroxylase deficiency and congenital adrenal hyperplasia
Cayman Chemical 13 14epoxy FlupROSnl Isop 10mg
An impurity generated in the production of travoprost; a 4:96 diastereomeric mixture of epoxides
Cayman Chemical RutaecarpIn 10mg
A quinazolinone alkaloid with diverse biological activities; inhibits COX-1 and COX-2 in BMMC cells (IC50s = 8.7 and 0.28 µM, respectively); selective for COX-2 in HEK293 cells (IC50s = >400 and 2.8 µM, for COX-1 and COX-2, respectively); slows cancer cell growth in vitro (GI50s = 8.41-31.6 µM); induces vasodilation (0.1-10 µM) in isolated rat aorta; decreases plasma levels of caffeine in rat through CYP1A2 and CYP2E1 metabolism induction at a dose of 80 mg/kg
Cayman Chemical S-Lnsoprazole 10mg
A proton pump inhibitor and pure enantiomer of lansoprazole; inhibits H+/K+-stimulated ATPase pumps in parietal cells (IC50 = 5.2 µM); inhibits acid formation in isolated canine parietal cells (IC50 = 82 µM)
Cayman Chemical BB22 3carboxyIndl metaol 10mg
An expected metabolite of BB-22 that would be detectable both in serum and urine; intended for forensic and research applications
Cayman Chemical 1 2DInonadecnoylsnglycero 10mg
A saturated phospholipid; has been used as a standard for the quantification of phosphatidylcholines in human synovial fluid; has been used to study dynamics of lipid bilayer phase transition
Cayman Chemical L-CarnItIn-d3chlorIde 10mg
An internal standard for the quantification of L-carnitine by GC- or LC-MS